Yim KL - Search Results

1

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.

Ghaneh P, Palmer D, Cicconi S, Jackson R, Halloran CM, Rawcliffe C, Sripadam R, Mukherjee S, Soonawalla Z, Wadsley J, Al-Mukhtar A, Dickson E, Graham J, Jiao L, Wasan HS, Tait IS, Prachalias A, Ross P, Valle JW, O'Reilly DA, Al-Sarireh B, Gwynne S, Ahmed I, Connolly K, Yim KL, Cunningham D, Armstrong T, Archer C, Roberts K, Ma YT, Springfeld C, Tjaden C, Hackert T, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer. Ghaneh P, et al. Among authors: yim kl. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168. doi: 10.1016/S2468-1253(22)00348-X. Epub 2022 Dec 12. Lancet Gastroenterol Hepatol. 2023. PMID: 36521500 Free article. Clinical Trial.

2

Correction to: Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study.

Kellam H, Yim KL. Kellam H, et al. Among authors: yim kl. J Diabetes Metab Disord. 2019 Sep 2;19(1):661. doi: 10.1007/s40200-019-00426-x. eCollection 2020 Jun. J Diabetes Metab Disord. 2019. PMID: 32550218 Free PMC article.

3

Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study.

Kellam H, Yim KL. Kellam H, et al. Among authors: yim kl. J Diabetes Metab Disord. 2018 Nov 15;17(2):247-252. doi: 10.1007/s40200-018-0366-2. eCollection 2018 Dec. J Diabetes Metab Disord. 2018. PMID: 30918860 Free PMC article.

4

Nab-paclitaxel in combination with gemcitabine for the treatment of metastatic pancreas cancer: the South Wales experience.

Quinton AE, Gwynne SH, Yim KL. Quinton AE, et al. Among authors: yim kl. Med Oncol. 2018 Jul 2;35(8):115. doi: 10.1007/s12032-018-1175-7. Med Oncol. 2018. PMID: 29968204

5

Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial.

Moorcraft SY, Chau I, Peckitt C, Cunningham D, Rao S, Yim KL, Walther A, Jackson CG, Stamp G, Webb J, Smith G, Gillbanks A, Swanton C. Moorcraft SY, et al. Among authors: yim kl. Invest New Drugs. 2013 Oct;31(5):1339-44. doi: 10.1007/s10637-013-9990-3. Epub 2013 Jun 26. Invest New Drugs. 2013. PMID: 23801302 Clinical Trial.

6

Radiotherapy as an effective primary treatment for epithelioid haemangioendothelioma of the cervical spine.

Yim KL, Sumathi VP, Spooner D. Yim KL, et al. Anticancer Res. 2012 Oct;32(10):4597-600. Anticancer Res. 2012. PMID: 23060592

7

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors.

Yim KL. Yim KL. Cancer Manag Res. 2012;4:207-14. doi: 10.2147/CMAR.S25979. Epub 2012 Jul 31. Cancer Manag Res. 2012. PMID: 22904642 Free PMC article.

8

Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma.

Yim KL, Ashley S. Yim KL, et al. Med Oncol. 2012 Dec;29(5):3535-9. doi: 10.1007/s12032-012-0309-6. Epub 2012 Jul 24. Med Oncol. 2012. PMID: 22825684

9

Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome.

Yim KL. Yim KL. Med Oncol. 2012 Sep;29(3):1796-801. doi: 10.1007/s12032-011-0050-6. Epub 2011 Sep 8. Med Oncol. 2012. PMID: 21901450 Review.

10

Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours.

Yim KL. Yim KL. Endocrine. 2011 Oct;40(2):181-6. doi: 10.1007/s12020-011-9513-y. Epub 2011 Aug 26. Endocrine. 2011. PMID: 21870172 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page